FDA Adverse Event Malfunction Summary report: N

0.8% RESOLVE PANEL A

MDR report key: 2869238 · Received December 12, 2012

Report

Report Number
2250051-2012-00298
Event Type
Malfunction
Date Received
December 12, 2012
Date of Event
November 28, 2012
Report Date
December 12, 2012
Manufacturer
ORTHO CLINICAL DIAGNOSTICS
Product Code
KSZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

OCD PERFORMED RETAINED TESTING AND A BATCH RECORD REVIEW. SATISFACTORY RESULTS WERE OBSERVED. COMPLAINT REVIEW WAS COMPLETED - THERE IS ONE SIMILAR COMPLAINT FOR LACK OF REACTIVITY WITH ANTI-E. (B)(4).

Description of Event or Problem · 1

CUSTOMER REPORTED THAT NO REACTIVITY WAS OBSERVED WITH VRA175 (E+ CELLS) AND A PATIENT SAMPLE IN WHICH AN ANTI-E WAS LATER IDENTIFIED. THE PATIENT'S INITIAL ANTIBODY SCREEN TEST WAS POSITIVE; REACTIVITY OBSERVED WITH CELLS I AND II. ANTIBODY ID PERFORMED AND ANTI-C WAS IDENTIFIED. ADDITIONAL TESTING WAS LATER PERFORMED USING 0.8% RESOLVE PANEL B AND OTHER TESTING IN TUBE/LISS AND AN ANTI-E WAS ALSO IDENTIFIED. CUSTOMER THEN REPEATED TESTING WITH VRA175 WITH INCREASED INCUBATION (20MIN). CUSTOMER OBSERVED WEAK - 1+ REACTIVITY WITH THE HOMOZYGOUS E+ CELL. CUSTOMER ALSO TESTED DONOR # (B)(6) FOR THE REACTIVITY OF THE E ANTIGEN AND OBSERVED A 4+ REACTION. PATIENT RECEIVED ONE UNIT OF C NEGATIVE, E NEGATIVE, BLOOD. PATIENT WAS NOT HARMED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 0.8% RESOLVE PANEL A REAGENT RED BLOOD CELLS KSZ ORTHO CLINICAL DIAGNOSTICS VRA175

Patients

Seq Age Sex Outcome Treatment
1